M. Gobert

发表

ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.

J. Blay, D. Olive, I. Treilleux, 2012, Cancer research.

Maternal-Fetal Immune Tolerance, Block by Block

J. Lafaille, M. Gobert, 2012, Cell.

Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.

J. Blay, I. Treilleux, C. Caux, 2012, Cancer research.

Focused Specificity of Intestinal Th17 Cells towards Commensal Bacterial Antigens

Jonathan L. Linehan, D. Littman, Yi Yang, 2014, Nature.

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

C. Caux, C. Ménétrier-Caux, M. Gobert, 2009, Cancer research.

is reversed by TLR 7 ligand treatment Tumor promotion by intratumoral plasmacytoid dendritic cells

J. Blay, I. Treilleux, C. Caux, 2013 .

Title 2 Quantitative and functional alterations of plasmacytoid dendritic 3 cells contribute to immune tolerance in ovarian cancer 4 Authors 5

J. Blay, I. Treilleux, I. Ray-Coquard, 2011 .

Lipid phosphate phosphatase 3 enables efficient thymic egress

R. Adams, A. Morris, J. Lafaille, 2011, The Journal of experimental medicine.

Early detection of tumor cells by innate immune cells leads to Treg recruitment through CCL 22 production by tumor cells Running title : innate immune recognition trigger CCL 22 by breast tumor cells

J. Blay, I. Treilleux, C. Caux, 2011 .

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

J. Blay, D. Olive, I. Treilleux, 2009, Cancer research.

Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells

J. Weiss, A. Rudensky, Michael Loran Dustin, 2012, The Journal of experimental medicine.

Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.

J. Blay, I. Treilleux, I. Ray-Coquard, 2011, Cancer research.

Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.

J. Blay, I. Treilleux, C. Caux, 2013, Cancer research.

Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.

J. Blay, I. Treilleux, C. Caux, 2011, Cancer research.

The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.

A. Morris, Manjula Sunkara, J. Lafaille, 2012, Cell reports.

Progression Regulatory T-cell Expansion That May Contribute to Breast Cancer Production by Plasmacytoid Dendritic Cells Favors α Impaired IFN-Updated

J. Blay, I. Treilleux, C. Caux, 2012 .

Impaired IFNa Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

J. Blay, I. Treilleux, C. Caux, 2012 .

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment

J. Blay, C. Caux, C. Ménétrier-Caux, 2012, Oncoimmunology.

Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia

Hossein Khiabanian, D. Herranz, G. Gómez-López, 2021, Theranostics.

Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.

J. Blay, I. Treilleux, C. Caux, 2012, Cancer research.

Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.

J. Blay, I. Treilleux, C. Caux, 2013, Cancer research.